Abstract:Despite low temperatures, poor nutrient levels and high pressure, microorganisms thrive in deep-sea environments of polar regions. The adaptability to such extreme environments renders deep-sea microorganisms an encouraging source of novel, bioactive secondary metabolites. In this study, we isolated 77 microorganisms collected by a remotely operated vehicle from the seafloor in the Fram Strait, Arctic Ocean (depth of 2454 m). Thirty-two bacteria and six fungal strains that represented the phylogenetic diversity of the isolates were cultured using an One-Strain-Many-Compounds (OSMAC) approach. The crude EtOAc extracts were tested for antimicrobial and anticancer activities. While antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA) and Enterococcus faecium was common for many isolates, only two bacteria displayed anticancer activity, and two fungi inhibited the pathogenic yeast Candida albicans. Due to bioactivity against C. albicans and rich chemical diversity based on molecular network-based untargeted metabolomics, Aspergillus versicolor PS108-62 was selected for an in-depth chemical investigation. A chemical work-up of the SPE-fractions of its dichloromethane subextract led to the isolation of a new PKS-NRPS hybrid macrolactone, versicolide A (1), a new quinazoline (−)-isoversicomide A (3), as well as three known compounds, burnettramic acid A (2), cyclopenol (4) and cyclopenin (5). Their structures were elucidated by a combination of HRMS, NMR, [α]D, FT-IR spectroscopy and computational approaches. Due to the low amounts obtained, only compounds 2 and 4 could be tested for bioactivity, with 2 inhibiting the growth of C. albicans (IC50 7.2 μg/mL). These findings highlight, on the one hand, the vast potential of the genus Aspergillus to produce novel chemistry, particularly from underexplored ecological niches such as the Arctic deep sea, and on the other, the importance of untargeted metabolomics for selection of marine extracts for downstream chemical investigations.

Structures, absolute configurations and bioogical activities of new unusual metabolites from sponge-associated Aspergillus sp

Isolation and Structure Elucidation of New Metabolites from the Mariana-Trench-Associated Fungus Aspergillus Sp. SY2601.

Structurally Unprecedented Metabolites from Marine Sponges

Secondary Metabolites, Biological Activities, and Industrial and Biotechnological Importance of Aspergillus sydowii

New austalides from the sponge-associated fungus aspergillus sp.

Bioactive Metabolites From The Mariana Trench Sediment-Derived Fungus Penicillium Sp. Sy2107

Novel Chromone Derivatives from Marine Fungus Aspergillus Versicolor Isolated from the Sponge Xestospongia Exigua

Novel Indole Diketopiperazine Stereoisomers from a Marine-Derived Fungus Aspergillus Sp

Four Novel Hydropyranoindeno-Derivatives from Marine Fungus Aspergillus Versicolor

A New Compound from the Marine-Derived Streptomyces Sp. SS13M

Studies on Diversity of Sponges-associated Fungi and Their Secondary Metabolites

Secondary metabolites from marine sponges of the genus Agelas : a comprehensive update insight on structural diversity and bioactivity

Minireview: Bioactive Compounds from Marine Bacteria and Fungi: Marine Bioactive Compounds

Cryptic Secondary Metabolites From The Sponge-Associated Fungus Aspergillus Ochraceus

Polyketide-derived Metabolites from the Sponge-Derived Fungus Aspergillus Sp F40

Research Advances of Bioactive Sesquiterpenoids Isolated from Marine-Derived Aspergillus sp

Secondary metabolites from the deep-sea derived fungus Aspergillus terreus MCCC M28183

Novel chromone derivatives from the fungus Aspergillus versicolor isolated from the marine sponge Xestospongia exigua.

Chemical and biological diversity of new natural products from marine sponges: a review (2009–2018)

Bioactivity and Metabolome Mining of Deep-Sea Sediment-Derived Microorganisms Reveal New Hybrid PKS-NRPS Macrolactone from Aspergillus versicolor PS108-62

Genomic and AntiSMASH Analyses of Marine-Sponge-Derived Strain Aspergillus niger L14 Unveiling Its Vast Potential of Secondary Metabolites Biosynthesis